Rituximab Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type ( 100 mg, 500 mg ); Route of Administration ( Intravenous, Subcutaneous ); Application ( Hematological Cancers, Autoimmune Diseases, Organ Transplants ) and Geography

Report Code: TIPRE00019327 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Rituximab is a medication used to treat certain autoimmune diseases and types of cancer and sold under the brand name Rituxan. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, idiopathic thrombocytopenic purpura, granulomatosis with polyangiitis, pemphigus vulgaris, myasthenia gravis, and Epstein-Barr virus-positive mucocutaneous ulcers. It is administered by slow injection into a vein.

MARKET DYNAMICS

Factors such increasing incidence of chronic disease (such as cancer, arthritis, and diabetes) and increasing research and drug development will spur the demand for Rituximab drug market. Additionally, strong clinical trial/product pipeline and entry of new pharmaceutical market players will boost the market growth to significant extent over the forecast period. However, side effects of the drug impede the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Rituximab Drug Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Rituximab drug market with detailed market segmentation by on type, route of administration, application and geography. The global Rituximab drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Rituximab drug market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global rituximab drug market is segmented on type, route of administration and application. Based on type, the global rituximab drug market is segmented into 100 mg and 500 mg. Based on route of administration, the global rituximab drug market is segmented into intravenous, and subcutaneous. Based on application, the global rituximab drug market is segmented into hematological cancers, autoimmune diseases, and organ transplants.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global rituximab drug market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Rituximab drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting rituximab drug market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Rituximab drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the rituximab drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from rituximab drug market are anticipated to lucrative growth opportunities in the future with the rising demand for rituximab drug market in the global market. Below mentioned is the list of few companies engaged in the rituximab drug market.

The report also includes the profiles of key rituximab drug market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   F. Hoffmann-La Roche Ltd
  •   Chugai Pharmaceutical Co., Ltd.
  •   Nippon Zenyaku Kogyo Co., Ltd.
  •   AryoGen Pharmed
  •   Intas Pharmaceuticals Ltd.
  •   Hetero
  •   Emcure Pharmaceuticals
  •   Nexus Lifecare Private Limited
  •   Reliance Life Sciences
  •   Actlife Sciences Private Limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rituximab Drug Market - By Type
1.3.2 Rituximab Drug Market - By Route of Administration
1.3.3 Rituximab Drug Market - By Application
1.3.4 Rituximab Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RITUXIMAB DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RITUXIMAB DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RITUXIMAB DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. RITUXIMAB DRUG - GLOBAL MARKET OVERVIEW
6.2. RITUXIMAB DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RITUXIMAB DRUG MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 100 MG
7.3.1. Overview
7.3.2. 100 mg Market Forecast and Analysis
7.4. 500 MG
7.4.1. Overview
7.4.2. 500 mg Market Forecast and Analysis
8. RITUXIMAB DRUG MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAVENOUS
8.3.1. Overview
8.3.2. Intravenous Market Forecast and Analysis
8.4. SUBCUTANEOUS
8.4.1. Overview
8.4.2. Subcutaneous Market Forecast and Analysis
9. RITUXIMAB DRUG MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. HEMATOLOGICAL CANCERS
9.3.1. Overview
9.3.2. Hematological Cancers Market Forecast and Analysis
9.4. AUTOIMMUNE DISEASES
9.4.1. Overview
9.4.2. Autoimmune Diseases Market Forecast and Analysis
9.5. ORGAN TRANSPLANTS
9.5.1. Overview
9.5.2. Organ Transplants Market Forecast and Analysis
10. RITUXIMAB DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Rituximab Drug Market Overview
10.1.2 North America Rituximab Drug Market Forecasts and Analysis
10.1.3 North America Rituximab Drug Market Forecasts and Analysis - By Type
10.1.4 North America Rituximab Drug Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Rituximab Drug Market Forecasts and Analysis - By Application
10.1.6 North America Rituximab Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Rituximab Drug Market
10.1.6.1.1 United States Rituximab Drug Market by Type
10.1.6.1.2 United States Rituximab Drug Market by Route of Administration
10.1.6.1.3 United States Rituximab Drug Market by Application
10.1.6.2 Canada Rituximab Drug Market
10.1.6.2.1 Canada Rituximab Drug Market by Type
10.1.6.2.2 Canada Rituximab Drug Market by Route of Administration
10.1.6.2.3 Canada Rituximab Drug Market by Application
10.1.6.3 Mexico Rituximab Drug Market
10.1.6.3.1 Mexico Rituximab Drug Market by Type
10.1.6.3.2 Mexico Rituximab Drug Market by Route of Administration
10.1.6.3.3 Mexico Rituximab Drug Market by Application
10.2. EUROPE
10.2.1 Europe Rituximab Drug Market Overview
10.2.2 Europe Rituximab Drug Market Forecasts and Analysis
10.2.3 Europe Rituximab Drug Market Forecasts and Analysis - By Type
10.2.4 Europe Rituximab Drug Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Rituximab Drug Market Forecasts and Analysis - By Application
10.2.6 Europe Rituximab Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Rituximab Drug Market
10.2.6.1.1 Germany Rituximab Drug Market by Type
10.2.6.1.2 Germany Rituximab Drug Market by Route of Administration
10.2.6.1.3 Germany Rituximab Drug Market by Application
10.2.6.2 France Rituximab Drug Market
10.2.6.2.1 France Rituximab Drug Market by Type
10.2.6.2.2 France Rituximab Drug Market by Route of Administration
10.2.6.2.3 France Rituximab Drug Market by Application
10.2.6.3 Italy Rituximab Drug Market
10.2.6.3.1 Italy Rituximab Drug Market by Type
10.2.6.3.2 Italy Rituximab Drug Market by Route of Administration
10.2.6.3.3 Italy Rituximab Drug Market by Application
10.2.6.4 Spain Rituximab Drug Market
10.2.6.4.1 Spain Rituximab Drug Market by Type
10.2.6.4.2 Spain Rituximab Drug Market by Route of Administration
10.2.6.4.3 Spain Rituximab Drug Market by Application
10.2.6.5 United Kingdom Rituximab Drug Market
10.2.6.5.1 United Kingdom Rituximab Drug Market by Type
10.2.6.5.2 United Kingdom Rituximab Drug Market by Route of Administration
10.2.6.5.3 United Kingdom Rituximab Drug Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Rituximab Drug Market Overview
10.3.2 Asia-Pacific Rituximab Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Rituximab Drug Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Rituximab Drug Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Rituximab Drug Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Rituximab Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Rituximab Drug Market
10.3.6.1.1 Australia Rituximab Drug Market by Type
10.3.6.1.2 Australia Rituximab Drug Market by Route of Administration
10.3.6.1.3 Australia Rituximab Drug Market by Application
10.3.6.2 China Rituximab Drug Market
10.3.6.2.1 China Rituximab Drug Market by Type
10.3.6.2.2 China Rituximab Drug Market by Route of Administration
10.3.6.2.3 China Rituximab Drug Market by Application
10.3.6.3 India Rituximab Drug Market
10.3.6.3.1 India Rituximab Drug Market by Type
10.3.6.3.2 India Rituximab Drug Market by Route of Administration
10.3.6.3.3 India Rituximab Drug Market by Application
10.3.6.4 Japan Rituximab Drug Market
10.3.6.4.1 Japan Rituximab Drug Market by Type
10.3.6.4.2 Japan Rituximab Drug Market by Route of Administration
10.3.6.4.3 Japan Rituximab Drug Market by Application
10.3.6.5 South Korea Rituximab Drug Market
10.3.6.5.1 South Korea Rituximab Drug Market by Type
10.3.6.5.2 South Korea Rituximab Drug Market by Route of Administration
10.3.6.5.3 South Korea Rituximab Drug Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Rituximab Drug Market Overview
10.4.2 Middle East and Africa Rituximab Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Rituximab Drug Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Rituximab Drug Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Rituximab Drug Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Rituximab Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Rituximab Drug Market
10.4.6.1.1 South Africa Rituximab Drug Market by Type
10.4.6.1.2 South Africa Rituximab Drug Market by Route of Administration
10.4.6.1.3 South Africa Rituximab Drug Market by Application
10.4.6.2 Saudi Arabia Rituximab Drug Market
10.4.6.2.1 Saudi Arabia Rituximab Drug Market by Type
10.4.6.2.2 Saudi Arabia Rituximab Drug Market by Route of Administration
10.4.6.2.3 Saudi Arabia Rituximab Drug Market by Application
10.4.6.3 U.A.E Rituximab Drug Market
10.4.6.3.1 U.A.E Rituximab Drug Market by Type
10.4.6.3.2 U.A.E Rituximab Drug Market by Route of Administration
10.4.6.3.3 U.A.E Rituximab Drug Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Rituximab Drug Market Overview
10.5.2 South and Central America Rituximab Drug Market Forecasts and Analysis
10.5.3 South and Central America Rituximab Drug Market Forecasts and Analysis - By Type
10.5.4 South and Central America Rituximab Drug Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Rituximab Drug Market Forecasts and Analysis - By Application
10.5.6 South and Central America Rituximab Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Rituximab Drug Market
10.5.6.1.1 Brazil Rituximab Drug Market by Type
10.5.6.1.2 Brazil Rituximab Drug Market by Route of Administration
10.5.6.1.3 Brazil Rituximab Drug Market by Application
10.5.6.2 Argentina Rituximab Drug Market
10.5.6.2.1 Argentina Rituximab Drug Market by Type
10.5.6.2.2 Argentina Rituximab Drug Market by Route of Administration
10.5.6.2.3 Argentina Rituximab Drug Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RITUXIMAB DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RITUXIMAB DRUG MARKET, KEY COMPANY PROFILES
13.1. F. HOFFMANN-LA ROCHE LTD
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CHUGAI PHARMACEUTICAL CO., LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NIPPON ZENYAKU KOGYO CO., LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ARYOGEN PHARMED
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. INTAS PHARMACEUTICALS LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HETERO
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. EMCURE PHARMACEUTICALS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NEXUS LIFECARE PRIVATE LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RELIANCE LIFE SCIENCES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ACTLIFE SCIENCES PRIVATE LIMITED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Chugai Pharmaceutical Co., Ltd.
3. Nippon Zenyaku Kogyo Co., Ltd.
4. AryoGen Pharmed
5. Intas Pharmaceuticals Ltd.
6. Hetero
7. Emcure Pharmaceuticals
8. Nexus Lifecare Private Limited
9. Reliance Life Sciences
10. Actlife Sciences Private Limited
TIPRE00019327
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking